The MHRA formally consults organisations representing public and professional interests, trade associations and industry on proposed statutory changes and other matters of importance regarding medicines through our MLXs.
We also consult on valid applications to change the legal status (prescription only, pharmacy or general sale list) of medicines; these consultations are given the prefix, 'ARM' (applications to reclassify medicines). At the end of the exercise copies of all non-confidential replies can be requested from our Information Centre, email info@mhra.gsi.gov.uk.
Latest medicines consultations
-
12 Jan 2012 | Public consultation (ARM 80): Request to reclassify Clarityn Allergy 10 mg Tablets (Loratadine) 30 tablet pack size from Pharmacy (P) to General Sales List (GSL)
Consultation ARM 80 seeks your views on the reclassification of Clarityn Allergy 10 mg Tablets (Loratadine) 30 tablet pack size from Pharmacy (P) to General Sales List (GSL). The deadline for comments is 8 February 2012.
-
11 Jan 2012 | Public consultation (MLX375): Consolidation and review of UK medicines legislation. Reminder - closes 17 January 2012
Consultation MLX 375 seeks your views on the draft consolidated medicines regulations. Reminder - closes 17 January 2012.
-
21 Dec 2011 | Public consultation (MLX 363): Fees legislation for 2012
This consultation seeks your views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homoeopathic medicines, and blood establishments and blood banks.
-
06 Dec 2011 | Public Consultation (MLX 374): Transposition of Pharmacovigilance Directive 2010/84/EU
Consultation MLX374 seeks your views on the draft regulations transposing the EU Directive 2010/84/EU on Pharmacovigilance. This Directive must be transposed to UK law by 21 July 2012. This is accompanied by EU Regulation 1235/2010/EU on Pharmacovigilance, to be transposed by 2 July 2012. Comments are invited by 28 February 2012.
-
07 Sep 2011 | Public consultation (ARM 79): Request to reclassify Grisol 1% Spray Solution from Pharmacy (P) to General Sales List (GSL)
Consultation ARM 79 seeks your views on the reclassification of Grisol 1% Spray Solution from P to GSL.
-
22 Jul 2011 | Public consultation (ARM 77): Request to reclassify Pariet Pharmacy 10 mg Gastro-Resistant tablet from Prescription Only Medicine (POM) to Pharmacy (P)
Consultation ARM 77 seeks your views on the reclassification of Pariet Pharmacy 10 mg Gastro-Resistant tablet from Prescription Only Medicine (POM) to Pharmacy (P).
-
28 Jun 2011 | Public consultation (ARM 76): Request to reclassify Savlon Cold Sore Cream from Pharmacy (P) to General Sale List (GSL)
Consultation ARM 76 seeks your views on the reclassification of Savlon Cold Sore Cream from Pharmacy (P) to General Sale List (GSL).
-
16 Mar 2011 | Public consultation (ARM 74) - Request to reclassify Crampex tablets from Pharmacy (P) to General Sales List (GSL)
Consultation ARM 74 seeks your views on the reclassification of Crampex Tablets from P to GSL.
-
09 Mar 2011 | Public consultation (MLX 364): The regulation of nicotine containing products (NCPs)
This consultation sought your views on whether to bring all nicotine containing products (NCPs) – with the exception of tobacco and tobacco products - within the medicines licensing regime. This would require all currently unlicensed NCPs on the market, such as electronic cigarettes containing nicotine and nicotine gels, to apply to the MHRA for a medicines marketing authorisation (MA).
-
03 Feb 2011 | Public consultation (ARM 73): Request to reclassify Ibusol lotion from Prescription Only Medicine (POM) to Pharmacy (P)
Consutation ARM 73 seeks your views on the reclassification of Ibusol lotion from Prescription Only Medicine (POM) to Pharmacy (P).
